Pfizer Promoting Tiered Drug Coverage Policy For Middle-Income Nations
Executive Summary
Pfizer is advocating a new U.S. trade stance toward setting parameters around foreign governments' drug reimbursement policies in middle-income nations
You may also be interested in...
Intellectual Property Bill Would Sanction Countries That Fail U.S. Rules
A Senate bill would block bank loans to countries that fail to implement intellectual property protections mandated by the U.S. government
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.